09.12.2012 Views

Second edition

Second edition

Second edition

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

08.qxd 3/10/08 9:38 AM Page 358<br />

358 Neurodegenerative and movement disorders<br />

picture and to unaffected relatives. Extensive counselling<br />

resources should be available for instances when the test is<br />

positive.<br />

8.11 CHOREOACANTHOCYTOSIS<br />

Choreoacanthocytosis, also known as chorea-acanthocytosis,<br />

is a rare autosomal recessively inherited disorder<br />

that typically manifests with chorea, as well as dementia in<br />

roughly half of cases; in all cases one also finds an excessive<br />

percentage of acanthocytic red blood cells. This last<br />

characteristic, namely acanthocytosis, qualifies choreoacanthocytosis<br />

as one member of a larger group of disorders<br />

known as the neuroacanthocytoses, which, as noted<br />

below in the discussion on differential diagnosis, includes<br />

such conditions as the McLeod syndrome.<br />

Clinical features<br />

The onset is generally in the late twenties or early thirties<br />

but may occur anywhere from late childhood to the seventh<br />

decade. Clinically (Critchley et al. 1968; Feinberg et al.<br />

1991; Hardie et al. 1991; Kartsounis and Hardie 1996;<br />

Lossos et al. 2005; Sakai et al. 1981), most cases present with<br />

a gradually progressive chorea, which, over time, is often<br />

joined by other abnormal movements, such as tics, dystonia,<br />

or a mild parkinsonism. A classic symptom, seen, however,<br />

in only a minority, is self-mutilating lip- or tongue-biting.<br />

Importantly, this self-mutilation is outside the patient’s<br />

control: one patient (Medalia et al. 1989), despite attempting<br />

to ‘restrain herself . . . by placing her fingers or a folded<br />

towel in her mouth . . . nevertheless had bleeding and<br />

scarred lesions of her oral mucosa and lips’. Most patients<br />

will also develop a sensorimotor peripheral poly-neuropathy,<br />

and, in a minority, seizures may occur. Roughly half of<br />

all patients will also develop a personality change, a<br />

dementia, or both.<br />

Acanthocytosis to a degree of 10 percent or more is seen<br />

on peripheral smears; importantly, the smears must be<br />

fresh wet preparations and, given the chance of false<br />

negatives, at least three smears should be examined<br />

(Hardie et al. 1991). Genetic testing is available.<br />

Creatinine kinase is elevated in most cases and MR<br />

scanning may reveal atrophy of the caudate nucleus.<br />

Course<br />

The disease is gradually progressive, with death, on average,<br />

after 14 years.<br />

Etiology<br />

Choreoacanthocytosis is an autosomal recessive condition<br />

occurring secondary to mutations in the VPS13A gene on<br />

chromosome 9q21 (formerly known as CHAC), which<br />

codes for a protein known as chorein. There may be considerable<br />

phenotypic heterogeneity in the same family.<br />

Macroscopically, there is atrophy of the caudate, putamen,<br />

and, to a lesser degree, the globus pallidus. Microscopically,<br />

neuronal loss and gliosis are seen in these<br />

structure and in the substantia nigra (Rinne et al. 1994b).<br />

Axonal loss occurs in the peripheral nerves (Hardie et al.<br />

1991; Ohnishi et al. 1981).<br />

Differential diagnosis<br />

The differential for chorea is discussed in Section 3.4; of<br />

the disorders considered there, several others, in addition<br />

to choreoacanthocytosis, present with chorea in early<br />

adult years and must be distinguished from choreoacanthocytosis.<br />

Huntington’s disease is marked by autosomal<br />

dominant inheritance and an absence of a peripheral<br />

neuropathy and, critically, a lack of acanthocytosis. As noted<br />

earlier, other disorders, in addition to choreoacanthocytosis,<br />

may also present with chorea and acanthocytosis, and these<br />

include the McLeod syndrome and Huntington’s diseaselike<br />

2 (Walker et al. 2002). The McLeod syndrome is distinguished<br />

by X-linked inheritance and Huntington’s<br />

disease-like 2 by an autosomal dominant pattern of inheritance.<br />

Genetic testing is available for all of these disorders.<br />

Treatment<br />

As for Huntington’s disease, chorea may be treated with<br />

antipsychotics; the general treatment of dementia is discussed<br />

in Section 5.1.<br />

8.12 FXTAS<br />

FXTAS, also known as the fragile X-associated tremor/ataxia<br />

syndrome, is a recently described inherited disorder characterized<br />

by the gradual development of tremor, ataxia, and, in<br />

a minority, dementia in middle-aged or older adults. This is<br />

not an uncommon disorder, and although cases have been<br />

reported in women (Hagerman et al. 2004), it is far more<br />

common in men.<br />

Clinical features<br />

Clinical features have been described in a number of<br />

papers (Greco et al. 2006; Hagerman et al. 2001; Hall et al.<br />

2005). Although the age of onset ranges from the fourth to<br />

the ninth decade, most patients fall ill in the seventh<br />

decade with the gradual onset of ataxia and tremor. The<br />

tremor, although typically of the intention type, may also<br />

have a rest or postural component. Over time, a mild<br />

parkinsonism may also accrue, with rest tremor, rigidity,

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!